The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Epithelial-mesenchymal transition in glioblastoma progression
Open accessAbstract
Epithelial-mesenchymal transition (EMT) is a reversible biological process that occurs in epithelial cells. EMT ultimately leads to the acquisition of a mesenchymal phenotype, characterized by increased cell motility and resistance to genotoxic agents. These processes mostly overlap with the acquirement of stem cell properties in differentiated tumor cells. With regard to gliomas, the clinical picture is heterogeneous, even within the same grades and histological categories of the disease. Furthermore, the areas of invasion and responses to radiochemotherapy are markedly different among cases, and occasionally even in the same patient. Such phenotypic diversity in glioma tissues may be caused by various microenvironmental factors, as well as intrinsic genetic alterations. The current review focuses on the EMT-inducing factors that are present in gliomas; these typically vary from those observed in epithelial cancers, as no basement membrane is present. Furthermore, the most important cell-cell contact factor, E-cadherin, is rarely expressed in gliomas. The microenvironment that induces EMT in gliomas is characterized by hypoxia and the enrichment of myeloid cells following stimulation by transforming growth factor-β. Anti-vascular endothelial growth factor therapy, including the use of bevacizumab, may be a suitable candidate to modulate the glioma microenvironment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
Verhaak, R. G. W., Hoadley, K. A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M. D., Miller, C. R., Ding, L., Golub, T., Mesirov, J. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.020 · Cited by 7,575
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., & Rich, J. N. (2006) · Nature · doi:10.1038/nature05236 · Cited by 6,379
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527 · cited 1×
“…important factors facilitating angiogenesis and resultant tumor growth in GBM. Inhibiting the VEGF-VEGF receptor (VEGFR) signal transduction pathway with anti-VEGF therapy (including the use of bevacizumab) and VEGFR inhibitors (including sunitinib) is a promising strategy in cancer therapy (80).”
Phillips, H. S., Kharbanda, S., Chen, R., Forrest, W. F., Soriano, R. H., Wu, T. D., Misra, A., Nigro, J. M., Colman, H., Soroceanu, L., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.02.019 · Cited by 3,143
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
Gilbert, M. R., Dignam, J. J., Armstrong, T. S., Wefel, J. S., Blumenthal, D. T., Vogelbaum, M. A., Colman, H., Chakravarti, A., Pugh, S., Won, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1308573 · Cited by 2,834
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
Chinot, O. L., Wick, W., Mason, W., Henriksson, R., Saran, F., Nishikawa, R., Carpentier, A. F., Hoang-Xuan, K., Kavan, P., Cernea, D., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1308345 · Cited by 2,557
Biomarkers for epithelial-mesenchymal transitions
Zeisberg, M., & Neilson, E. G. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36183 · Cited by 2,299 · cited 12×
“Slug is another member of the SNAIL family of transcriptional activators and serves an important role in suppressing the epithelial phenotype in numerous cancer cells (1,2,44).”
BackgroundInfluentialAn integral program for tissue renewal and regeneration: Wnt signaling and stem cell control
Clevers, H., Loh, K. M., & Nusse, R. (2014) · Science · doi:10.1126/science.1248012 · Cited by 1,364
Zeisberg, M., Hanai, J.-I., Sugimoto, H., Mammoto, T., Charytan, D., Strutz, F., & Kalluri, R. (2003) · Nature Medicine · doi:10.1038/nm888 · Cited by 1,346
Direct regulation of TWIST by HIF-1α promotes metastasis
Yang, M.-H., Wu, M.-Z., Chiou, S.-H., Chen, P.-M., Chang, S.-Y., Liu, C.-J., Teng, S.-C., & Wu, K.-J. (2008) · Nature Cell Biology · doi:10.1038/ncb1691 · Cited by 1,345
TGFβ: the molecular Jekyll and Hyde of cancer
Bierie, B., & Moses, H. L. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1926 · Cited by 1,267
Mesenchymal Differentiation Mediated by NF-κB Promotes Radiation Resistance in Glioblastoma
Bhat, K. P. L., Balasubramaniyan, V., Vaillant, B., Ezhilarasan, R., Hummelink, K., Hollingsworth, F., Wani, K., Heathcock, L., James, J. D., Goodman, L. D., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.08.001 · Cited by 1,102
BIRCHMEIER, W., & BEHRENS, J. (1994) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(94)90003-5 · Cited by 1,002
Inactivation of the E-Cadherin-Mediated Cell Adhesion System in Human Cancers
Hirohashi, S. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65575-7 · Cited by 839
Heddleston, J. M., Li, Z., McLendon, R. E., Hjelmeland, A. B., & Rich, J. N. (2009) · Cell Cycle · doi:10.4161/cc.8.20.9701 · Cited by 813
Murat, A., Migliavacca, E., Gorlia, T., Lambiv, W. L., Shay, T., Hamou, M.-F., de Tribolet, N., Regli, L., Wick, W., Kouwenhoven, M. C. M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.7164 · Cited by 721
The brain tumor microenvironment
Charles, N. A., Holland, E. C., Gilbertson, R., Glass, R., & Kettenmann, H. (2011) · Glia · doi:10.1002/glia.21136 · Cited by 718
The brain tumor microenvironment
Charles, N. A., Holland, E. C., Gilbertson, R., Glass, R., & Kettenmann, H. (2012) · Glia · doi:10.1002/glia.21264 · Cited by 712
Yu, Y., Xiao, C.-H., Tan, L.-D., Wang, Q.-S., Li, X.-Q., & Feng, Y.-M. (2014) · British Journal of Cancer · doi:10.1038/bjc.2013.768 · Cited by 676
Fan, X., Khaki, L., Zhu, T. S., Soules, M. E., Talsma, C. E., Gul, N., Koh, C., Zhang, J., Li, Y.-M., Maciaczyk, J., et al. (2010) · Stem Cells · doi:10.1002/stem.254 · Cited by 651
To differentiate or not — routes towards metastasis
Brabletz, T. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3265 · Cited by 623
Anido, J., Sáez-Borderías, A., Gonzàlez-Juncà, A., Rodón, L., Folch, G., Carmona, M. A., Prieto-Sánchez, R. M., Barba, I., Martínez-Sáez, E., Prudkin, L., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.10.023 · Cited by 572
EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness
Sánchez-Tilló, E., Liu, Y., de Barrios, O., Siles, L., Fanlo, L., Cuatrecasas, M., Darling, D. S., Dean, D. C., Castells, A., & Postigo, A. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1122-2 · Cited by 518
Ye, X.-Z., Xu, S.-L., Xin, Y.-H., Yu, S.-C., Ping, Y.-F., Chen, L., Xiao, H.-L., Wang, B., Yi, L., Wang, Q.-L., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103248 · Cited by 477
DIRECT EVIDENCE FOR A ROLE OF β‐CATENIN/LEF‐1 SIGNALING PATHWAY IN INDUCTION OF EMT
Kim, K., Lu, Z., & Hay, E. D. (2002) · Cell Biology International · doi:10.1006/cbir.2002.0901 · Cited by 428
Bhowmick, N. A., Zent, R., Ghiassi, M., McDonnell, M., & Moses, H. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106176200 · Cited by 388
Bar, E. E., Lin, A., Mahairaki, V., Matsui, W., & Eberhart, C. G. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.091021 · Cited by 373
The ZEB1/miR‐200 feedback loop controls Notch signalling in cancer cells
Brabletz, S., Bajdak, K., Meidhof, S., Burk, U., Niedermann, G., Firat, E., Wellner, U., Dimmler, A., Faller, G., Schubert, J., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2010.349 · Cited by 369
Induction of the neural crest: a multigene process
Knecht, A. K., & Bronner-Fraser, M. (2002) · Nature Reviews Genetics · doi:10.1038/nrg819 · Cited by 361
Hypoxia Is Important in the Biology and Aggression of Human Glial Brain Tumors
Evans, S. M., Judy, K. D., Dunphy, I., Jenkins, W. T., Hwang, W.-T., Nelson, P. T., Lustig, R. A., Jenkins, K., Magarelli, D. P., Hahn, S. M., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1081 · Cited by 356
Snail activation disrupts tissue homeostasis and induces fibrosis in the adult kidney
Boutet, A., De Frutos, C. A., Maxwell, P. H., Mayol, M. J., Romero, J., & Nieto, M. A. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601421 · Cited by 327
TWIST1 promotes invasion through mesenchymal change in human glioblastoma
Mikheeva, S. A., Mikheev, A. M., Petit, A., Beyer, R., Oxford, R. G., Khorasani, L., Maxwell, J.-P., Glackin, C. A., Wakimoto, H., González-Herrero, I., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-194 · Cited by 289
Jensen, R. L. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-9827-2 · Cited by 287
Møller, H. G., Rasmussen, A. P., Andersen, H. H., Johnsen, K. B., Henriksen, M., & Duroux, M. (2013) · Molecular Neurobiology · doi:10.1007/s12035-012-8349-7 · Cited by 266
Zhang, M., Kleber, S., Röhrich, M., Timke, C., Han, N., Tuettenberg, J., Martin-Villalba, A., Debus, J., Peschke, P., Wirkner, U., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1212 · Cited by 249
Kahlert, U. D., Maciaczyk, D., Doostkam, S., Orr, B. A., Simons, B., Bogiel, T., Reithmeier, T., Prinz, M., Schubert, J., Niedermann, G., et al. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.05.024 · Cited by 231
Cooper, L. A. D., Gutman, D. A., Chisolm, C., Appin, C., Kong, J., Rong, Y., Kurc, T., Van Meir, E. G., Saltz, J. H., Moreno, C. S., et al. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.01.040 · Cited by 230
Piao, Y., Liang, J., Holmes, L., Zurita, A. J., Henry, V., Heymach, J. V., & de Groot, J. F. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos158 · Cited by 227
E-Cadherin loss associated with EMT promotes radioresistance in human tumor cells
Theys, J., Jutten, B., Habets, R., Paesmans, K., Groot, A. J., Lambin, P., Wouters, B. G., Lammering, G., & Vooijs, M. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.05.044 · Cited by 221
Epithelial-to-mesenchymal(-like) transition as a relevant molecular event in malignant gliomas
Kahlert, U. D., Nikkhah, G., & Maciaczyk, J. (2013) · Cancer Letters · doi:10.1016/j.canlet.2012.12.010 · Cited by 219
A Twist in fate: evolutionary comparison of Twist structure and function
Castanon, I., & Baylies, M. K. (2002) · Gene · doi:10.1016/s0378-1119(01)00893-9 · Cited by 217
Xu, Y., Stamenkovic, I., & Yu, Q. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2505 · Cited by 214
CD44 mediates human glioma cell adhesion and invasion in vitro.
Merzak, A., Koochekpour, S., & Pilkington, G. J. (1994) · PubMed · Cited by 212
Dumont, N., Wilson, M. B., Crawford, Y. G., Reynolds, P. A., Sigaroudinia, M., & Tlsty, T. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807146105 · Cited by 210
FoxM1 and Wnt/β-Catenin Signaling in Glioma Stem Cells
Gong, A., & Huang, S. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0953 · Cited by 208
Acquired Resistance to Anti-VEGF Therapy in Glioblastoma Is Associated with a Mesenchymal Transition
Piao, Y., Liang, J., Holmes, L., Henry, V., Sulman, E., & de Groot, J. F. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1557 · Cited by 200
Brain tumor stem cells: Molecular characteristics and their impact on therapy
Schonberg, D. L., Lubelski, D., Miller, T. E., & Rich, J. N. (2014) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2013.06.004 · Cited by 198
Shi, Z., Zhang, J., Qian, X., Han, L., Zhang, K., Chen, L., Liu, J., Ren, Y., Yang, M., Zhang, A., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0280 · Cited by 190
TWIST is Expressed in Human Gliomas, Promotes Invasion
Elias, M. C., Tozer, K. R., Silber, J. R., Mikheeva, S., Deng, M., Morrison, R. S., Manning, T. C., Silbergeld, D. L., Glackin, C. A., Reh, T. A., et al. (2005) · Neoplasia · doi:10.1593/neo.04352 · Cited by 176
Qi, S., Song, Y., Peng, Y., Wang, H., Long, H., Yu, X., Li, Z., Fang, L., Wu, A., Luo, W., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038842 · Cited by 172
Mahabir, R., Tanino, M., Elmansuri, A., Wang, L., Kimura, T., Itoh, T., Ohba, Y., Nishihara, H., Shirato, H., Tsuda, M., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/not239 · Cited by 165
Molecular Classification and Survival Prediction in Human Gliomas Based on Proteome Analysis
Iwadate, Y., Sakaida, T., Hiwasa, T., Nagai, Y., Ishikura, H., Takiguchi, M., & Yamaura, A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1254 · Cited by 164
Self-citationCurrent Understanding on EGFR and Wnt/ -Catenin Signaling in Glioma and Their Possible Crosstalk
Paul, I., Bhattacharya, S., Chatterjee, A., & Ghosh, M. K. (2013) · Genes & Cancer · doi:10.1177/1947601913503341 · Cited by 158
Jin, X., Jeon, H.-Y., Joo, K. M., Kim, J.-K., Jin, J., Kim, S.-H., Kang, B. G., Beck, S. J., Lee, S. J., Kim, J. K., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1495 · Cited by 156
SNAI2/Slug promotes growth and invasion in human gliomas
Yang, H. W., Menon, L. G., Black, P. M., Carroll, R. S., & Johnson, M. D. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-301 · Cited by 154
Zhou, Y., Liu, J.-Y., Li, J., Zhang, J., Xu, Y., Zhang, H.-W., Qiu, L.-B., Ding, G., Su, X., Mei-Shi, et al. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.06.1956 · Cited by 148
Bullock, M. D., Sayan, A. E., Packham, G., & Mirnezami, A. H. (2011) · Biology of the Cell · doi:10.1111/boc.201100115 · Cited by 140
Timke, C., Zieher, H., Roth, A. K., Hauser, K., Lipson, K. E., Weber, K. J., Debus, J., Abdollahi, A., & Huber, P. E. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1893 · Cited by 137
Cheng, W., Kandel, J. J., Yamashiro, D. J., Canoll, P., & Anastassiou, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034705 · Cited by 132
Effect of Brain- and Tumor-Derived Connective Tissue Growth Factor on Glioma Invasion
Edwards, L., Woolard, K., Son, M. J., Li, A., Lee, J., Ene, C. I., Mantey, S. A., Maric, D., Song, H., Belova, G. I., et al. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr224 · Cited by 123
EMT or apoptosis: a decision for TGF-β
Song, J. (2007) · Cell Research · doi:10.1038/cr.2007.25 · Cited by 122
Recruited Brain Tumor‐Derived Mesenchymal Stem Cells Contribute to Brain Tumor Progression
Behnan, J., Isakson, P., Joel, M., Cilio, C., Langmoen, I. A., Vik-Mo, E. O., & Badn, W. (2013) · Stem Cells · doi:10.1002/stem.1614 · Cited by 112
Sandberg, C. J., Altschuler, G. M., Jeong, J., Kierulf-Vieira, K. S., Stangeland, B., Murrell, W. G., Grasmo-Wendler, U.-H., Myklebost, O., Helseth, E., Vik-Mo, E. O., et al. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.06.004 · Cited by 105
MicroRNAs and glioblastoma; the stem cell connection
Godlewski, J., Newton, H. B., Chiocca, E. A., & Lawler, S. E. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.71 · Cited by 86
Zarkoob, H., Taube, J. H., Singh, S. K., Mani, S. A., & Kohandel, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064169 · Cited by 80
Hu, Y., Fu, L.-A., Li, S., Chen, Y., Li, J., Han, J., Liang, L., Li, L., Ji, C., Zheng, M., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.03.035 · Cited by 77
MicroRNAs in hematopoietic development
Montagner, S., Dehò, L., & Monticelli, S. (2014) · BMC Immunology · doi:10.1186/1471-2172-15-14 · Cited by 75
Evaluation of the prognostic value of CD44 in glioblastoma multiforme.
Wei, K., Huang, C. Y., Chen, P. Y., Feng, L. Y., Wu, T.-W. E., Chen, S.-M., Tsai, H., Lin, Y.-J., Tsang, N., Tseng, C. K., et al. (2010) · PubMed · Cited by 72
A radiosensitivity gene signature in predicting glioma prognostic via EMT pathway
Meng, J., Li, P., Zhang, Q., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2088 · Cited by 71
Radiation promotes malignant progression of glioma cells through HIF-1alpha stabilization
Kim, Y.-H., Yoo, K.-C., Cui, Y., Uddin, N., Lim, E.-J., Kim, M., Nam, S.-Y., Kim, I., Suh, Y., & Lee, S. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.07.048 · Cited by 64
Šáňa, J., Lakomý, R., Hajdúch, M., & Slabý, O. (2012) · Cited by 58
Nagaishi, M., Paulus, W., Brokinkel, B., Vital, A., Tanaka, Y., Nakazato, Y., Giangaspero, F., & Ohgaki, H. (2012) · Brain Pathology · doi:10.1111/j.1750-3639.2012.00571.x · Cited by 52
Kristoffersen, K., Villingshøj, M., Poulsen, H. S., et al. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.24595 · Cited by 47
Baysan, M. S., Woolard, K., Bozdag, S., Riddick, G., Kotliarova, S. E., Cam, M. C., Belova, G. I., Ahn, S. J., Zhang, W., Song, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094045 · Cited by 46
MicroRNA-16 suppresses epithelial-mesenchymal transition-related gene expression in human glioma
Wang, Q., Xu, L., Zhu, Y. T., & Yang, P. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2583 · Cited by 44
microRNAs and Cardiac Cell Fate
Piubelli, C., Meraviglia, V., Pompilio, G., D’Alessandra, Y., Colombo, G. I., & Rossini, A. (2014) · Cells · doi:10.3390/cells3030802 · Cited by 44
Non-coding RNAs as epigenetic regulator of glioma stem-like cell differentiation
Katsushima, K., & Kondo, Y. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00014 · Cited by 35
CDA-2 induces cell differentiation through suppressing Twist/SLUG signaling via miR-124 in glioma
Xie, Y., Huo, S., Zhang, G., Zhang, F., Lian, Z., Tang, X., & Jin, C. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-012-0961-x · Cited by 33
Notch Signaling and Brain Tumors
Stockhausen, M., Kristoffersen, K., & Poulsen, H. S. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0899-4_22 · Cited by 28
Cited by
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
Dongre, A., & Weinberg, R. A. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0080-4 · Cited by 3,876
Glioblastoma hijacks neuronal mechanisms for brain invasion
Venkataramani, V., Yang, Y., Schubert, M. C., Reyhan, E., Tetzlaff, S. K., Wißmann, N., Botz, M., Soyka, S. J., Beretta, C. A., Pramatarov, R. L., et al. (2022) · Cell · doi:10.1016/j.cell.2022.06.054 · Cited by 632
Brain malignancies: Glioblastoma and brain metastases
Lah, T. T., Novak, M., & Breznik, B. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.10.010 · Cited by 438
Wnt/β-catenin signaling pathway in carcinogenesis and cancer therapy
Song, P., Gao, Z., Bao, Y., Chen, L., Huang, Y., Liu, Y., Dong, Q., & Wei, X. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01563-4 · Cited by 382
3D‐Bioprinted Mini‐Brain: A Glioblastoma Model to Study Cellular Interactions and Therapeutics
Heinrich, M. A., Bansal, R., Lammers, T., Zhang, Y. S., Michel Schiffelers, R., & Prakash, J. (2019) · Advanced Materials · doi:10.1002/adma.201806590 · Cited by 317
Metadata
- Authors
- IWADATE, Y.
- Venue
- Oncology Letters
- Publisher
- Spandidos Publications
- Published
- 2016-01-14
- Volume
- 11
- Issue
- 3
- Pages
- 1615-1620
- ISSN
- 1792-1074 (ISSN-L)
- 1792-1082
- OpenAlex
- W2236918265
- Cited by
- 288
- References
- 82
- FWCI
- 17.23
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.